1979
DOI: 10.1203/00006450-197910000-00010
|View full text |Cite
|
Sign up to set email alerts
|

Lysine Intolerance in a Variant Form of Citrullinemia

Abstract: Summary MATERIALS AND METHODSAn oral loading of lysine (100 mg of lysine-HCL/kg) was performed in two patients, I&and 23-yr-old, with a variant form of citrullinemia.Serum citrulline levels were approximately 10 times higher than control level and lysine levels were within the normal range, in contrast to the classical form of the disease in which serum citrulline is approximately 100 times normal levels and hyperlysinemia is usually present.After lysine loading, lysine levels rose sharply and clearance was de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

1981
1981
1987
1987

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…Homocitrulline can be converted by argininosuccinate synthetase (EC 6.3.4.5) to homoargininosuccinate which is further metabolized to homoarginine (Strand- , 1971;Ratner, 1973). However, the appearance of homoargininuria in citrullinaemia due to argininosuccinate synthetase deficiency (Scott-Enmakpor et al, 1972;Matsuda et al, 1979) suggests that homoarginine is directly formed from lysine by transamidinating tysine via glycine transamidinase (EC 2.1.4.1) (Ryan et al, 1969). Inasmuch as arginine is used as a substrate in this metabolism and if homoarginine is metabolized to urea by arginase (Ryan et al, 1968;Paik et al, 1977), excess arginine and arginase deficiency may result in marked accumulation of homoarginine in hyperargininaemia.…”
Section: Discussionmentioning
confidence: 99%
“…Homocitrulline can be converted by argininosuccinate synthetase (EC 6.3.4.5) to homoargininosuccinate which is further metabolized to homoarginine (Strand- , 1971;Ratner, 1973). However, the appearance of homoargininuria in citrullinaemia due to argininosuccinate synthetase deficiency (Scott-Enmakpor et al, 1972;Matsuda et al, 1979) suggests that homoarginine is directly formed from lysine by transamidinating tysine via glycine transamidinase (EC 2.1.4.1) (Ryan et al, 1969). Inasmuch as arginine is used as a substrate in this metabolism and if homoarginine is metabolized to urea by arginase (Ryan et al, 1968;Paik et al, 1977), excess arginine and arginase deficiency may result in marked accumulation of homoarginine in hyperargininaemia.…”
Section: Discussionmentioning
confidence: 99%
“…As indicated, most cases of citrullinaemia in Japan are a variant form of the disease (Matsuda et al, 1979a;Saheki et al, 1981), in which a few cases had a qualitative ASA synthetase abnormality shown by altered kinetic properties (Matsuda et al, 1976;Saheki et al, 1981;Matsuda, 1979b), indicating a structure gene mutation. Most cases in Japan have a quantitative abnormality of ASA synthetase (Saheki et al, 1981).…”
Section: Discussionmentioning
confidence: 96%
“…Citrullinaemia (McKusick 21570) is a urea cycle disorder associated with deficient activity of argininosuccinate (ASA) synthetase (L-citrulline:L-aspartate ligase, EC6.3.4.5). At least three forms are found: a classical form whose onset occurs during infancy with periodic vomiting, seizures and mental retardation (McMurray et al, 1963); a rapid form which is fatal in the neonate (Van der Zee et at., 1971) with elevated serum citrulline levels appoximately 100 times the control level; and a variant form whose onset is in childhood or later, with seizures, stupor, usually but not always mental retardation, and a less elevated serum citrulline level, approximately 10-30 times the control level (Matsuda et al, 1976(Matsuda et al, , 1979a. In addition, even in patients with the same clinical form, genetic heterogeneities were identified by detailed biochemical studies (Kennaway et at., 1975;Saheki et al, 1981).…”
mentioning
confidence: 99%